Aquestive Therapeutics Inc
Company Overview
Aquestive Therapeutics is a pharmaceutical company that focuses on developing and commercializing differentiated products to address unmet medical needs. The company specializes in creating oral film-based drug delivery systems. Their main products include treatments for epilepsy, ALS (Lou Gehrig's disease), and other central nervous system conditions.
The company uses its proprietary PharmFilm technology platform to develop medicines that can be administered through oral films, providing alternatives to traditional drug delivery methods. This technology aims to improve the therapeutic outcomes and quality of life for patients who may have difficulty swallowing pills or using other delivery methods.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $13.54m | $26.03m | - | $4.2m | 0.00% | 16.13% |
| June 30, 2024 | $20.1m | $24.24m | - | $4.2m | 0.00% | 17.31% |
| March 31, 2024 | $12.05m | $25.21m | - | $4.2m | 0.00% | 16.66% |
Company Impact
Help us evaluate Aquestive Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.